Alberti A - Search Results

1

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S; ECC Jury. Alberti A, et al. J Hepatol. 2005 May;42(5):615-24. doi: 10.1016/j.jhep.2005.03.003. J Hepatol. 2005. PMID: 15916745 Review. No abstract available.

2

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.

Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, Badalamenti S, Trépo C. Pradat P, et al. Among authors: alberti a. Hepatology. 2002 Oct;36(4 Pt 1):973-7. doi: 10.1053/jhep.2002.35530. Hepatology. 2002. PMID: 12297846

3

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Cammà C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, Pockros PJ, Marcellin P, Balart L, Alberti A, Craxì A. Cammà C, et al. Among authors: alberti a. Hepatology. 2004 Feb;39(2):333-42. doi: 10.1002/hep.20073. Hepatology. 2004. PMID: 14767986

4

A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.

Marcolongo M, Young B, Dal Pero F, Fattovich G, Peraro L, Guido M, Sebastiani G, Palù G, Alberti A. Marcolongo M, et al. Among authors: alberti a. Hepatology. 2009 Oct;50(4):1038-44. doi: 10.1002/hep.23111. Hepatology. 2009. PMID: 19676127

5

Management of hepatitis C.

Alberti A, Benvegnù L. Alberti A, et al. J Hepatol. 2003;38 Suppl 1:S104-18. doi: 10.1016/s0168-8278(03)00008-4. J Hepatol. 2003. PMID: 12591189 Review. No abstract available.

6

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.

Kershenobich D, Razavi HA, Cooper CL, Alberti A, Dusheiko GM, Pol S, Zuckerman E, Koike K, Han KH, Wallace CM, Zeuzem S, Negro F. Kershenobich D, et al. Among authors: alberti a. Liver Int. 2011 Jul;31 Suppl 2:4-17. doi: 10.1111/j.1478-3231.2011.02535.x. Liver Int. 2011. PMID: 21651700

7

Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C.

Cammà C, Petta S, Cabibbo G, Ruggeri M, Enea M, Bruno R, Capursi V, Gasbarrini A, Alberti A, Craxì A; WEF Study Group. Cammà C, et al. Among authors: alberti a. J Hepatol. 2013 Oct;59(4):658-66. doi: 10.1016/j.jhep.2013.05.019. Epub 2013 May 23. J Hepatol. 2013. PMID: 23707373

8

Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?

Alberti A. Alberti A. J Hepatol. 2004 Jun;40(6):1032-5. doi: 10.1016/j.jhep.2004.04.008. J Hepatol. 2004. PMID: 15158348 Review. No abstract available.

9

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.

Alberti A. Alberti A. J Hepatol. 2005 Feb;42(2):266-74. doi: 10.1016/j.jhep.2004.12.004. J Hepatol. 2005. PMID: 15664254 Review. No abstract available.

10

Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin.

Dal Pero F, Tang KH, Gerotto M, Bortoletto G, Paulon E, Herrmann E, Zeuzem S, Alberti A, Naoumov NV. Dal Pero F, et al. Among authors: alberti a. J Infect Dis. 2007 Oct 1;196(7):998-1005. doi: 10.1086/521306. Epub 2007 Aug 21. J Infect Dis. 2007. PMID: 17763320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,157 results

Search Page

Filters